Explore

Trendline Trendline
North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035
Trendline Trendline
SKYRIZI® Gains Approval for Ulcerative Colitis Treatment in Ontario and Alberta

SKYRIZI® Gains Approval for Ulcerative Colitis Treatment in Ontario and Alberta

SKYRIZI® Gains Approval for Ulcerative Colitis Treatment in Ontario and Alberta
Trendline Trendline
Marriott International Raises $8.4 Million for Children's Miracle Network, Supporting Local Hospitals

Marriott International Raises $8.4 Million for Children's Miracle Network, Supporting Local Hospitals

Marriott International Raises $8.4 Million for Children's Miracle Network, Supporting Local Hospitals
Rapid Read Rapid Read
Baylor College of Medicine Unveils New Alzheimer's Treatment Strategy Targeting Astrocytes

Baylor College of Medicine Unveils New Alzheimer's Treatment Strategy Targeting Astrocytes

Researchers at Baylor College of Medicine have discovered a novel approach to combat Alzheimer's disease by enhancing the brain's natural cleanup system. The study, published in Nature Neuroscience, focuses on astrocytes, star-shaped support cells in the brain, which play a crucial role in maintaining brain stability and memory storage. The research team, led by Dr. Dong-Joo Choi and Dr. Benjamin Deneen, found that increasing the levels of a protein called Sox9 in mice with Alzheimer's symptoms activated astrocytes to clear harmful amyloid plaques. This process, known as phagocytosis, was facilitated by a receptor called MEGF10, which Sox9 helps regulate. The study demonstrated that boosting Sox9 levels reduced plaque accumulation and preserved cognitive function in mice over six months.
Rapid Read Rapid Read
Baylor College of Medicine Researchers Uncover Protein Boost to Combat Alzheimer's

Baylor College of Medicine Researchers Uncover Protein Boost to Combat Alzheimer's

Researchers at Baylor College of Medicine have discovered a method to activate a natural cleanup system in the brain that could combat Alzheimer's disease. The study, published in Nature Neuroscience, highlights the role of astrocytes, support cells in the brain, in removing harmful amyloid plaques. By increasing the levels of a protein called Sox9 in mice, researchers observed enhanced activity in astrocytes, leading to the clearance of these plaques and preservation of memory. This approach contrasts with traditional treatments that focus on preventing plaque formation or protecting neurons. The study suggests that enhancing the brain's own defense mechanisms could offer a new strategy for treating Alzheimer's.
Rapid Read Rapid Read
Health Canada Approves Generic Versions of Ozempic, Paving Way for Cost Savings

Health Canada Approves Generic Versions of Ozempic, Paving Way for Cost Savings

Health Canada has approved two generic versions of the diabetes drug Ozempic, making Canada the first G7 country to do so. The approval follows the expiration of Ozempic's patent in Canada, allowing for the introduction of generic alternatives. The approved generics, produced by Dr. Reddy’s Laboratories and Apotex, are expected to offer a more affordable option for patients. Generic medications typically cost 45 to 90 percent less than their brand-name counterparts, which could significantly reduce expenses for Canadians who rely on this medication for managing type 2 diabetes and weight loss.
Rapid Read Rapid Read
Health Canada Approves Generic Versions of Ozempic, Impacting Drug Costs

Health Canada Approves Generic Versions of Ozempic, Impacting Drug Costs

Health Canada has approved two generic versions of the diabetes drug Ozempic, marking Canada as the first G7 country to do so. The patent for Ozempic, originally held by Novo Nordisk, expired in early January, allowing for the introduction of generic alternatives. The approved generics are from Dr. Reddy’s Laboratories and Canadian-based Apotex. These generic versions are expected to be significantly cheaper, potentially reducing costs for patients who currently pay high out-of-pocket expenses for the medication. Health Canada assures that these generics are pharmaceutically equivalent to the brand-name drug, maintaining safety and efficacy standards.
Rapid Read Rapid Read
Study Explores Brain Network Activity in Parkinson's Disease Patients

Study Explores Brain Network Activity in Parkinson's Disease Patients

A recent study has investigated the association between cortical large-scale networks and subthalamic nucleus (STN) activity in patients with Parkinson's disease. The research involved 27 patients who had undergone deep brain stimulation (DBS) electrode implantation in the STN. The study aimed to understand how different brain networks interact with the STN, particularly during various states of medication. Using magnetoencephalography (MEG) recordings, the researchers analyzed the brain activity of these patients both on and off dopaminergic medication. The study found significant patterns of STN-cortical coherence, which varied depending on the medication state and the specific brain networks activated. This research provides insights into the dynamic brain network interactions in Parkinson's disease, potentially informing future therapeutic strategies.
Rapid Read Rapid Read
Baylor College of Medicine Researchers Discover Protein Boost to Combat Alzheimer's

Baylor College of Medicine Researchers Discover Protein Boost to Combat Alzheimer's

Researchers at Baylor College of Medicine have identified a process that can remove amyloid plaques from the brains of mouse models with Alzheimer's disease, potentially preserving memory and cognitive function. The study, published in Nature Neuroscience, focuses on astrocytes, which are support cells in the brain. By increasing levels of the protein Sox9, researchers found that astrocytes could more effectively clear amyloid plaques, which are toxic deposits associated with Alzheimer's. This discovery suggests a new treatment strategy that enhances the brain's natural support system to slow cognitive decline in neurodegenerative diseases.
SB Nation SB Nation
Jon Scheyer Lands Another Portal Guard

Jon Scheyer Lands Another Portal Guard

Between Boumtje-Boumtje, the Prime deal, and Theodosiu, it’s been a really interesting week for Duke Basketball.
Rapid Read Rapid Read
Detroit Plans New Transportation Hub Near Michigan Central to Boost Connectivity

Detroit Plans New Transportation Hub Near Michigan Central to Boost Connectivity

The Detroit Transportation Corporation is moving forward with plans to develop a new transportation hub near Michigan Central. The project aims to expand public transit options in metro Detroit, potentially connecting the region to Chicago and Canada. The hub is strategically located near an existing railroad, which could facilitate its operation as an Amtrak station. The initiative is part of broader efforts to enhance regional connectivity and improve public transportation infrastructure. The project is expected to commence in the summer of 2026.
Rapid Read Rapid Read
Iranian Soccer Chief's Entry to Canada and Subsequent Departure Raises Questions

Iranian Soccer Chief's Entry to Canada and Subsequent Departure Raises Questions

Mehdi Taj, the president of the Iranian soccer federation and a former member of the Islamic Revolutionary Guard Corps (IRGC), was allowed entry into Canada for a FIFA Congress in Vancouver. Despite being cleared by Canadian officials, Taj and his delegation chose to return to Iran after being held and questioned for three hours at a Toronto airport. The Canadian government has a policy barring IRGC members from entering the country, but Taj was permitted entry after clarifying his ties to the group. Taj's decision to leave Canada voluntarily has sparked discussions about the complexities of international travel for individuals with affiliations to controversial organizations.